The approval of QUVIVIQ™, a novel dual orexin receptor antagonist, is based on robust clinical efficacy and safety data, including from a Phase 3 trial in Japan that met all primary and secondary ...
Yasutaka Uchiyama (No. 160) will meet Sumit Nagal (No. 82) in the Round of 32 at the Hangzhou Open on Thursday, September 19. Nagal was last in action on August 26, 2024 at the US Open, where he ...